Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209-49. doi:10.3322/caac.21660.

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394-424. doi: 10.3322/caac.21492.

International Agency for Research on Cancer. Islamic Republic of Iran. The global cancer observatory;2021.

Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut 2017;66:683-91. doi: 10.1136/gutjnl-2015-310912.

Hasanpour-Heidari S, Fazel A, Semnani S, et al. Temporal and geographical variations in colorectal cancer incidence in Northern Iran 2004-2013. Cancer Epidemiol 2019;59:143-7. doi:10.1016/j.canep.2019.02.003.

Roshandel G, Ghanbari-Motlagh A, Partovipour E, et al. Cancer incidence in Iran in 2014: results of the Iranian National Population-based Cancer Registry. Cancer Epidemiol 2019;61:50-8. doi:10.1016/j.canep.2019.05.009.

Somi MH, Dolatkhah R, Sepahi S, Belalzadeh M, Naghashi S, Asghari Jafarabadi M. A 12-year trend analysis of the incidence of gastrointestinal cancers in East Azerbaijan: last updated results of an ongoing population-based cancer registry. BMC Cancer 2019;19:782. doi:10.1186/s12885-019-6008-3.

Somi MH, Dolatkhah R, Sepahi S, et al. Cancer incidence in the East Azerbaijan province of Iran in 2015–2016: results of a population-based cancer registry. BMC Public Health 2018;18:1266. https://doi.org/10.1186/s12889-018-6119-9.

Maajani K, Khodadost M, Fattahi A, et al. Survival rate of colorectal cancer in Iran: A systematic review and meta-analysis. Asian Pac J Cancer Prev 2019;20:13-21. doi:10.31557/APJCP.2019.20.1.13.

Saadati HM, Khodamoradi F, Salehiniya H. Associated factors of survival rate and screening for colorectal cancer in Iran: a systematic review. J Gastrointest Cancer 2020;51:401-11. doi:10.1007/s12029-019-00275-0.

Tahmasbi B, Abedi G, Moosazadeh M, et al. Determining the survival rate of colorectal cancer in Iran: a systematic review and meta-analysis. Asian Pac J Cancer Prev 2018;19:3009-18. doi:10.31557/APJCP.2018.19.11.3009.

Dolatkhah R, Somi MH, Kermani IA, et al. Increased colorectal cancer incidence in Iran: a systematic review and meta-analysis. BMC Public Health 2015;15:997. doi:10.1186/s12889-015-2342-9.

Khanali J, Kolahi AA. National and subnational cancer incidence for 22 cancer groups, 2000 to 2016: a study based on cancer registration data of Iran. J Cancer Epidemiol 2021;2021:6676666. doi:10.1155/2021/6676666.

Young C, Wood HM, Seshadri RA, et al. The colorectal cancer-associated faecal microbiome of developing countries resembles that of developed countries. Genome Med 2021;13:27. doi:10.1186/s13073-021-00844-8.

Roshandel G, Ghanbari-Motlagh A, Partovipour E, et al. Cancer incidence in Iran in 2014: results of the Iranian national population-based cancer registry. Cancer Epidemiol 2019;61:50-8. doi: 10.1016/j.canep.2019.05.009.

Fitzmaurice C, Abate D, Abbasi N, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the Global Burden of Disease study. JAMA Oncol 2019;5:1749-68. doi:10.1001/jamaoncol.2019.2996.

Cheung KS, Chen L, Seto WK, Leung WK. Epidemiology, characteristics, and survival of post-colonoscopy colorectal cancer in Asia: A population-based study. J Gastroenterol Hepatol 2019;34:1545-53. doi:10.1111/jgh.14674.

Li X, Zhou Y, Luo Z, et al. The impact of screening on the survival of colorectal cancer in Shanghai, China: a population based study. BMC Public Health 2019;19:1016. doi:10.1186/s12889-019-7318-8.

American Cancer Society. Survival rates for colorectal cancer. Atlanta: American Cancer Society;2021.

Kassim SA, Tang W, Abbas M, et al. Clinicopathologic and epidemiological characteristics of prognostic factors in post-surgical survival of colorectal cancer patients in Jiangsu Province, China. Cancer Epidemiol 2019;62:101565. doi:10.1016/j.canep.2019.07.004.

Almansoori A, Alzaabi M, Alketbi L. Colorectal cancer screening in ambulatory healthcare service clinics in Abu Dhabi, United Arab Emirates in 2015-2016. BMC Cancer 2021;21:897. doi:10.1186/s12885-021-08623-9.

Hassan MRA, Suan MA, Soelar SA, Mohammed NS, Ismail I, Ahmad F. Survival analysis and prognostic factors for colorectal cancer patients in Malaysia. Asian Pac J Cancer Prev 2016;17:3575-81.

Rasouli MA, Moradi G, Roshani D, Nikkhoo B, Ghaderi E, Ghaytasi B. Prognostic factors and survival of colorectal cancer in Kurdistan province, Iran: a population-based study (2009-2014). Medicine (Baltimore) 2017;96:e5941. doi:10.1097/MD.0000000000005941.

Vasudevan S, Mehta A. Clinical characteristics and survival profile of young versus old colorectal cancer patients at a tertiary cancer center in North India over a period of 5 years. Indian J Cancer 2020. doi:10.4103/ijc.IJC_246_19.

Hu S, Li S, Teng D, et al. Analysis of risk factors and prognosis of 253 lymph node metastasis in colorectal cancer patients. BMC Surg 2021;21:280. doi:10.1186/s12893-021-01276-2.

Destri GL, Barchitta M, Pesce A, et al. Predictive value of the number of harvested lymph nodes and cut-off for lymph node ratio in the prognosis of stage II and III colorectal cancer patients. J Invest Surg 2019;32:1-7. doi:10.1080/08941939.2017.1369605.

Li Q, Wang G, Luo J, Li B, Chen W. Clinicopathological factors associated with synchronous distant metastasis and prognosis of stage T1 colorectal cancer patients. Sci Rep 2021;11:8722. doi:10.1038/s41598-021-87929-x.

Borumandnia N, Doosti H, Jalali A, et al. Nomogram to predict the overall survival of colorectal cancer patients: a multicenter national study. Int J Environ Res Public Health 2021;18: 7734. doi:10.3390/ijerph18157734.

Madadizadeh F, Ghanbarnejad A, Ghavami V, Bandamiri MZ, Mohammadianpanah M. Applying additive hazards models for analyzing survival in patients with colorectal cancer in Fars Province, Southern Iran. Asian Pac J Cancer Prev 2017;18:1077-83. doi:10.22034/APJCP.2017.18.4.1077.

Hosseini SV, Rezaianzadeh A, Rahimikazerooni S, et al. Prognostic factors of rectal cancer in Southern Iran. J Gastrointest Cancer 2020. doi:10.1007/s12029-020-00553-2.

Jalaeikhoo H, Khajeh-Mehrizi A, Zokaasadi M, et al. Sixteen years of experience with the treatment of advanced colorectal cancer in Iran; a report from three institutions. Middle East J Dig Dis 2018;10:160-8. doi:10.15171/mejdd.2018.105.

Moamer S, Baghestani A, Pourhoseingholi MA, Hajizadeh N, Ahmadi F, Norouzinia M. Evaluation of prognostic factors effect on survival time in patients with colorectal cancer, based on Weibull Competing-Risks Model. Gastroenterol Hepatol Bed Bench 2017;10:54-9.